Newly Emerging Infectious Disease

Total Page:16

File Type:pdf, Size:1020Kb

Newly Emerging Infectious Disease Perspective Where Do Emerging Pathogens Come from? Understanding the origins of pathogens will help us to combat emerging infectious diseases Mark E. J. Woolhouse nfectious diseases continue to impose a caused a minor public health problem but still huge global public health burden, ac- had severe economic repercussions for affected counting for more than one-quarter of countries; and there is considerable concern I all deaths annually and a similar fraction about the possible emergence of a new subtype of morbidity. In addition to long-estab- of influenza A, with potentially devastating, lished infections such as malaria, tuberculosis, global consequences. and measles, we are also seeing the frequent The evolving nature of infectious disease emergence of new infectious diseases: HIV/ problems is a challenge to microbiologists on AIDS was unknown 25 years ago and is now one several different levels. There are practical chal- of the biggest killers; the virus responsible for lenges, such as developing diagnostics, treat- severe acquired respiratory syndrome (SARS) ments, and vaccines, and of designing effective surveillance and intervention strategies. Plus, there are intellectual challenges, in- cluding understanding the complex and Summary multifaceted causes of the emergence and • Emerging and re-emerging infectious diseases spread of new pathogens and the reemer- pose both practical and intellectual challenges, gence of those previously thought to be in including understanding their complex causes; decline. Neither the practical nor intellec- developing diagnostics, treatments, and vac- cines; and designing effective surveillance and tual challenges are likely to be met without intervention strategies. developing more effective working partner- • Of the catalogued pathogen species that infect ships among those in various disciplines, at humans, 538 are bacteria, 317 are fungi, 287 different institutions, and living in different are helminths, 208 are viruses, and 57 are pro- nations. tozoa; among those associated with emerging and re-emerging infectious disease, viruses are significantly over-represented, whereas hel- minths are under-represented. Pathogen Diversity • Species jumps by pathogens require both the opportunity and capacity to infect a new host A human pathogen can be defined as “a species; recent species jumps have usually in- microbial or parasite species that can infect volved RNA viruses, perhaps because their ge- and is capable of causing disease in humans netic lability allows them to adapt quickly to a under natural transmission conditions.” Mark Woolhouse is new host species. Professor of Infec- • Recently emerging or re-emerging pathogens Humans are affected by an impressive diver- tious Disease Epi- most often are RNA viruses having a taxonom- sity of pathogens. My colleagues Sonya ically broad host range, using a phylogenetically Gowtage-Sequeira, Ben Evans, and I re- demiology at the conserved cell receptor, being transmissible be- cently surveyed the recent literature, build- Centre for Infec- tween humans, and occurring in regions under- ing on earlier work by Louise Taylor and tious Diseases, Uni- going ecological, demographic or social change. Sophie Latham, and found 1,407 currently versity of Edin- recognized species of human pathogen. burgh, U.K. Volume 1, Number 11, 2006 / Microbe Y 511 FIGURE 1 category, with viruses significantly overrepresented and helminths under- represented. Within the scope of our survey, we found reports of 38 apparently novel human pathogen species associated with emerging diseases during the past 25 years (Fig. 1). Some species within this category likely were active before they were identified. For example, al- though HIV-1 was first reported in 1983, it is thought to have begun infect- ing humans several decades earlier. Two-thirds of these novel species are RNA viruses, a finding that may partly be due to ascertainment bias through improved viral diagnostics, especially PCR-based technologies. However, several inherent features of RNA virus biology may also help to explain why there are so many of them in this cate- gory. The accumulation of newly reported human pathogen species since 1980. The total of 38 Importance of Animal Reservoirs species includes only those associated with emerging infectious disease problems; newly recognized etiological agents of existing disease problems (e.g. Helicobacter Relatively few pathogen species—per- pylori, associated with peptic ulcers, or metapneumovirus, causing respiratory infections) are excluded. Also excluded are novel variants of known species, such as the O157:H7 haps no more than 100—do nothing serotype of E. coli and the H5N1 subtype of influenza A virus. The dates of emergence other than infect and cause disease in of some key examples discussed in the text are highlighted. humans. Many of them are commensals that do not ordinarily cause disease; many others are distributed in the wider Of course, a species count provides only environment such as water or soil; and yet oth- a simple measure of pathogen diversity. Much ers also infect host species other than humans. medically important variation—in traits such as The latter category constitutes the zoonoses, virulence factors, immunogenicity, and drug re- which the World Health Organization (WHO) sistance—occurs within pathogen species as defines as “diseases or infections which are nat- well as between them. However, focusing on urally transmitted between vertebrate animals species proves revealing. Of the catalogued and humans.” Almost 60% of human pathogen pathogen species that infect humans, 538 are species are zoonotic. A small minority of these, bacteria, 317 are fungi, 287 are helminths, 208 the “anthroponoses,” are mainly passed from are viruses, and 57 are protozoa. Within this humans to animals rather than the other way taxonomic diversity, individual species manifest around: measles virus, for example, is essentially a wide variety of life cycles, transmission routes, a human virus that also can infect great apes. pathogenicities, and epidemiologies. But for hundreds of human pathogen species, an We are particularly interested in pathogens animal reservoir is an important feature of their associated with emerging and reemerging infec- biology. tious diseases. These are defined by the Centers The most striking feature of such animal res- for Disease Control and Prevention (CDC) as ervoirs is their diversity. We share our patho- “diseases of infectious origin whose incidence in gens with ungulates, carnivores, rodents, pri- humans has increased within the past two de- mates, sometimes other kinds of mammals such cades or threatens to increase in the near fu- as bats, and also nonmammals, especially birds. ture.” Of the species in our survey, 177 cause Many of the reservoirs are domestic animals, diseases that are regarded as falling into this but just as many are wildlife species. These pat- 512 Y Microbe / Volume 1, Number 11, 2006 terns apply to the whole range of pathogens from viruses to helminths. Examples of human pathogens emerging via species jump Stephen Morse at Columbia University Pathogen Original host Year reported suggested more than 10 years ago that emerging and reemerging pathogens were Ebola virus Bats(?) 1977 Escherichia coli O157:H7 Cattle 1982 disproportionately zoonotic, and subsequent Borrelia burgdorferi Rodents(?) 1982 research has confirmed his observation. HIV-1 Chimpanzees 1983 Emerging and reemerging zoonoses are not HIV-2 Primates 1986 associated with any particular animal reser- Hendra virus Bats 1994 voirs but they are associated with pathogens vCJD Cattle 1996 Australian bat lyssavirus Bats 1996 that can infect several different kinds of H5N1 influenza A virus Chickens 1997 hosts. Nipah virus Bats 1999 Several recently emerged human patho- SARS coronavirus Palm civets(?) 2003 gens illustrate these findings. Examples are the SARS coronavirus and the agent respon- sible for bovine spongiform encephalopathy jumps, are poorly understood. One key factor, (BSE), both of which are zoonotic and can infect at least for viral pathogens, appears to be their a wide variety of animals and recently appeared use of cell receptors that are phylogenetically in humans. Even some novel pathogens that are conserved across a range of host species. not now regarded as zoonotic, such as HIV-1, The ability to infect a host species is merely were acquired by humans from animals. the first step; invading the new host species also These are but a few recent examples of a depends on the ability to transmit between indi- process that has been going on for millennia. vidual hosts within a species. Many emerging Jared Diamond of the University of California, pathogens have no or very limited transmissibil- Los Angeles, is among those who note that ity between humans, including variant Creutz- many of the most serious infectious diseases of feldt Jakob disease (vCJD), lyssavirus, influenza humans, including measles, influenza, and A subtype H5N1, and Borrelia burgdorferi, smallpox, likely have animal origins. which causes Lyme disease. Other poorly trans- mitted pathogens cause self-limiting outbreaks, including Ebola virus and Escherichia coli Invading New Host Populations O157:H7. Meanwhile, some pathogens such as When a pathogen of one host species first in- the SARS coronavirus spread much more freely vades a new one, it is called a “species jump” among their newly acquired human hosts. (see table). Successful species jumps require both The quantitative framework
Recommended publications
  • Human Illness Caused by E. Coli O157:H7 from Food and Non-Food Sources
    FRI BRIEFINGS Human Illness Caused by E. coli O157:H7 from Food and Non-food Sources M. Ellin Doyle1*, John Archer2, Charles W. Kaspar1, and Ronald Weiss1 1Food Research Institute, University of Wisconsin–Madison, Madison, WI 53706 2Wisconsin Division of Public Health, Bureau of Communicable Diseases and Preparedness, Communicable Disease Epidemiology Section, Madison, WI 53702 Contents Introduction ...................................................................................................................................2 Epidemiology of E. coli O157:H7..................................................................................................2 Outbreak Data ........................................................................................................................2 Reservoirs of E. coli O157:H7 ..............................................................................................3 Cattle—the primary reservoir ........................................................................................3 Other ruminants .............................................................................................................4 Other animals .................................................................................................................4 Transport Hosts......................................................................................................................4 Routes of Human Infection ....................................................................................................5
    [Show full text]
  • How Do Pathogenic Microorganisms Develop Cross-Kingdom Host Jumps? Peter Van Baarlen1, Alex Van Belkum2, Richard C
    Molecular mechanisms of pathogenicity: how do pathogenic microorganisms develop cross-kingdom host jumps? Peter van Baarlen1, Alex van Belkum2, Richard C. Summerbell3, Pedro W. Crous3 & Bart P.H.J. Thomma1 1Laboratory of Phytopathology, Wageningen University, Wageningen, The Netherlands; 2Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands; and 3CBS Fungal Biodiversity Centre, Utrecht, The Netherlands Correspondence: Bart P.H.J. Thomma, Abstract Downloaded from https://academic.oup.com/femsre/article/31/3/239/2367343 by guest on 27 September 2021 Laboratory of Phytopathology, Wageningen University, Binnenhaven 5, 6709 PD It is common knowledge that pathogenic viruses can change hosts, with avian Wageningen, The Netherlands. Tel.: 10031 influenza, the HIV, and the causal agent of variant Creutzfeldt–Jacob encephalitis 317 484536; fax: 10031 317 483412; as well-known examples. Less well known, however, is that host jumps also occur e-mail: [email protected] with more complex pathogenic microorganisms such as bacteria and fungi. In extreme cases, these host jumps even cross kingdom of life barriers. A number of Received 3 July 2006; revised 22 December requirements need to be met to enable a microorganism to cross such kingdom 2006; accepted 23 December 2006. barriers. Potential cross-kingdom pathogenic microorganisms must be able to First published online 26 February 2007. come into close and frequent contact with potential hosts, and must be able to overcome or evade host defences. Reproduction on, in, or near the new host will DOI:10.1111/j.1574-6976.2007.00065.x ensure the transmission or release of successful genotypes.
    [Show full text]
  • Differences in Innate Immune Response Between Man and Mouse
    Institute of Medical Physics and Biophysics Medical Department, Leipzig University Author Manuscript © 2014. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ Published in final edited form as: Critical Reviews™ in Immunology, 2014; 34:433-54. Available at: http://dx.doi.org/ 10.1615/CritRevImmunol.2014011600. DIFFERENCES IN INNATE IMMUNE RESPONSE BETWEEN MAN AND MOUSE Josefin Zschaler 1,2,*, Denise Schlorke 1,2,* & Juergen Arnhold 1,2 1 Institute for Medical Physics and Biophysics, Medical Faculty, Leipzig University, Leipzig, Germany 2 Translational Centre for Regenerative Medicine (TRM), Leipzig University, Leipzig, Germany * Both authors contributed equally to this work. Abstract Mouse strains are frequently used to model human disease states, to test the efficiency of drugs and therapeutic principles. However, the direct translation of murine experimental data to human pathological events often fails due to sufficient differences in the organization of the immune system of both species. Here we give a short overview of the principle differences between mice and humans in defense strategies against pathogens and mechanisms involved in response to pathogenic microorganisms and other activators of the immune system. While in human blood mechanisms of immune resistance are highly prevailed, tolerance mechanisms dominate for the defense against pathogenic microorganisms in mouse blood. Further on, species-related differences of immune cells mainly involved in innate immune response as well as differences to maintain oxidative homeostasis are also considered. A number of disease scenarios in mice are critically reflected for their suitability to serve as a model for human pathologies.
    [Show full text]
  • The Public Health Impact of Prion Diseases1
    10 Feb 2005 13:10 AR AR238-PU26-08.tex AR238-PU26-08.sgm LaTeX2e(2002/01/18) P1: IBD 10.1146/annurev.publhealth.26.021304.144536 Annu. Rev. Public Health 2005. 26:191–212 doi: 10.1146/annurev.publhealth.26.021304.144536 Copyright ©c 2005 by Annual Reviews. All rights reserved First published online as a Review in Advance on December 8, 2004 THE PUBLIC HEALTH IMPACT OF PRION DISEASES1 Ermias D. Belay and Lawrence B. Schonberger Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333; email: [email protected] KeyWords transmissible spongiform encephalopathy, Creutzfeldt-Jakob disease, variant Creutzfeldt-Jakob disease, bovine spongiform encephalopathy, chronic wasting disease ■ Abstract Several prion disease–related human health risks from an exogenous source can be identified in the United States, including the iatrogenic transmission of Creutzfeldt-Jakob disease (CJD), the possible occurrence of variant CJD (vCJD), and potential zoonotic transmission of chronic wasting disease (CWD). Although cross- species transmission of prion diseases seems to be limited by an apparent “species barrier,” the occurrence of bovine spongiform encephalopathy (BSE) and its transmis- sion to humans indicate that animal prion diseases can pose a significant public health risk. Recent reports of secondary person-to-person spread of vCJD via blood products and detection of vCJD transmission in a patient heterozygous at codon 129 further illustrate the potential public health impacts of BSE. INTRODUCTION by IRMO/Information Center on 03/14/05. For personal use only. Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group of animal and human brain diseases that are uniformly fatal and often characterized by a long incubation period and a multifocal neuropathologic picture of neuronal loss, spongiform changes, and astrogliosis (3).
    [Show full text]
  • Innate Immunity Part I: the Immediate Response Deborah A
    Innate Immunity Part I: The Immediate Response Deborah A. Lebman, Ph.D. OBJECTIVES 1. Describe three mechanisms present at epithelial surfaces that protect the host from pathogens. 2. List 3 functions of complement proteins in innate immunity 3. Know the primary functions of macrophages and neutrophils 4. List the receptors on macrophages involved in recognition of pathogens 5. List the key toxic products of phagocytes READING • Parham, The Immune System, pg 227-238. TERMS • Defensin: antibacterial peptide produced by the host at epithelial surfaces • Complement: ubiquitously present proteins synthesized primarily in the liver that mediate a variety of responses to pathogens • Opsonin (opsonization): alteration of cell surface that facilitates phagocytosis • Phagocytosis: internalization of particulate matter by cells • CD14: LPS receptor • TLR-4: toll like receptor 4 I. Introduction A. The first response to pathogens occurs immediately B. The early response employs both mechanical and cell mediated mechanisms C. There is no cellular expansion, but there is cell recruitment D. A wide array of soluble mediators with both positive and negative effects, i.e. remove the pathogen but hurt the host, is released II. Overview of Pathogens A. There are four types of pathogen: bacteria, virus, fungus, parasite B. Table I: Examples of the Four Types of Common Human Pathogen Table 1: Examples of the Four Types of Common Human Pathogen Table 1 (Continued): Examples of the Four Types of Common Human Pathogen C. Pathogens can be intracellular or extracellular Table 2: Examples of intracellular and extracellular pathogens. Notice that both innate and adaptive mechanisms are involved in the response to both types of pathogen.
    [Show full text]
  • Supporting Information
    Supporting Information Rosenberg et al. 10.1073/pnas.1307243110 SI Results and Discussion domestic ungulates (horses, cows, sheep, goats, camels, and pigs) Of the 83 arboviruses, nonhuman vertebrate hosts have been and rodents in both groups might be a consequence of spatial identified for 70 (84%); the remaining 13 are presumed to be proximity to humans. Sentinel monkeys were often used in pro- zoonoses because there is no indication they can be transmitted cedures to isolate arboviruses, which might account for their directly between humans by vectors (Table S1). Animal hosts have higher representation among arboviruses. In contrast, there are been identified for at least 57 (44%) of the 130 nonarboviruses; an few published records of bats being routinely sampled during additional 5 (8%) are presumed on epidemiological evidence to arbovirus studies, and only two arboviruses (3%) have been iso- have nonhuman reservoirs (Table S1). A number of viruses infect lated from bats. The reason a much larger number of arbovirus more than one nonhuman vertebrate host species and it is likely species (n = 16) have been isolated from birds than have that the variety of hosts is wider than has been recorded. The nonarbovirus species (n = 1) might, however, be characteristic of predominant host groups for arboviruses (n = 70) are nonhuman the pathogenicity of the togaviruses and flaviviruses, which are primates (31%), rodents (29%), ungulates (26%), and birds (23%); much more common among the arboviruses. The most prominent for the nonarboviruses (n = 57), they are rodents (30%), ungu- vectors of arboviruses were mosquitoes (67%), ticks (19%), and lates (26%), bats (23%), and primates (16%).
    [Show full text]
  • Spillback in the Anthropocene: the Risk of Human-To-Wildlife Pathogen Transmission for Conservation and Public Health
    Spillback in the Anthropocene: the risk of human-to-wildlife pathogen transmission for conservation and public health Anna C. Fagre*1, Lily E. Cohen2, Evan A. Eskew3, Max Farrell4, Emma Glennon5, Maxwell B. Joseph6, Hannah K. Frank7, Sadie Ryan8, 9,10, Colin J Carlson11,12, Gregory F Albery*13 *Corresponding authors: [email protected]; [email protected] 1: Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 2: Icahn School of Medicine at Mount Sinai, New York, NY 10029 3: Department of Biology, Pacific Lutheran University, Tacoma, WA, 98447 USA 4: Department of Ecology & Evolutionary Biology, University of Toronto 5: Disease Dynamics Unit, Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK 6: Earth Lab, University of Colorado Boulder, Boulder, CO 80309 7: Department of Ecology and Evolutionary Biology, Tulane University, New Orleans, LA, 70118 USA 8: Quantitative Disease Ecology and Conservation (QDEC) Lab Group, Department of Geography, University of Florida, Gainesville, FL, 32610 USA 9: Emerging Pathogens Institute, University of Florida, Gainesville, FL, 32610 USA 10: School of Life Sciences, University of KwaZulu-Natal, Durban, 4041, South Africa 11: Center for Global Health Science and Security, Georgetown University Medical Center, Washington, DC, 20057 USA 12: Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, 20057 USA 13: Department of Biology, Georgetown University, Washington, DC, 20057 USA 1 Abstract The SARS-CoV-2 pandemic has led to increased concern over transmission of pathogens from humans to animals (“spillback”) and its potential to threaten conservation and public health.
    [Show full text]
  • Risk of Human Pathogen Internalization in Leafy Vegetables During Lab-Scale Hydroponic Cultivation
    horticulturae Review Risk of Human Pathogen Internalization in Leafy Vegetables During Lab-Scale Hydroponic Cultivation Gina M. Riggio 1, Sarah L. Jones 2 and Kristen E. Gibson 2,* 1 Cellular and Molecular Biology Program, Department of Food Science, University of Arkansas, Fayetteville, AR 72701, USA; [email protected] 2 Department of Food Science, University of Arkansas, Fayetteville, AR 72704, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-479-575-6844 Received: 13 February 2019; Accepted: 7 March 2019; Published: 15 March 2019 Abstract: Controlled environment agriculture (CEA) is a growing industry for the production of leafy vegetables and fresh produce in general. Moreover, CEA is a potentially desirable alternative production system, as well as a risk management solution for the food safety challenges within the fresh produce industry. Here, we will focus on hydroponic leafy vegetable production (including lettuce, spinach, microgreens, and herbs), which can be categorized into six types: (1) nutrient film technique (NFT), (2) deep water raft culture (DWC), (3) flood and drain, (4) continuous drip systems, (5) the wick method, and (6) aeroponics. The first five are the most commonly used in the production of leafy vegetables. Each of these systems may confer different risks and advantages in the production of leafy vegetables. This review aims to (i) address the differences in current hydroponic system designs with respect to human pathogen internalization risk, and (ii) identify the preventive control points for reducing risks related to pathogen contamination in leafy greens and related fresh produce products. Keywords: hydroponic; leafy greens; internalization; pathogens; norovirus; Escherichia coli; Salmonella; Listeria spp.; preventive controls 1.
    [Show full text]
  • Genomics-Based Re-Examination of the Taxonomy and Phylogeny Of
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Food and Drug Administration Papers U.S. Department of Health and Human Services 2020 Genomics-based re-examination of the taxonomy and phylogeny of human and simian Mastadenoviruses: an evolving whole genomes approach, revealing putative zoonosis, anthroponosis, and amphizoonosis June Kang George Mason University Ashrafali Mohamed Ismail Harvard Medical School Shoaleh Dehghan George Mason University Jaya Rajaiya Harvard Medical School FMarollowc W this. Allar andd additional works at: https://digitalcommons.unl.edu/usfda US Food & Drug Administration Part of the Dietetics and Clinical Nutrition Commons, Health and Medical Administration Commons, Health Services Administration Commons, Pharmaceutical Preparations Commons, and the Pharmacy AdministrSee next pageation, for Policy additional and Regulation authors Commons Kang, June; Ismail, Ashrafali Mohamed; Dehghan, Shoaleh; Rajaiya, Jaya; Allard, Marc W.; Lim, Haw Chuan; Dyer, David W.; Chodosh, James; and Seto, Donald, "Genomics-based re-examination of the taxonomy and phylogeny of human and simian Mastadenoviruses: an evolving whole genomes approach, revealing putative zoonosis, anthroponosis, and amphizoonosis" (2020). Food and Drug Administration Papers. 47. https://digitalcommons.unl.edu/usfda/47 This Article is brought to you for free and open access by the U.S. Department of Health and Human Services at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Food and
    [Show full text]
  • Laboratory Activities to Enhance the Study of Whole Blood Components and Their Role in the Immune Response
    Laboratory Activities to Enhance the Study of Whole Blood Components and their Role in the Immune Response Thomas E. Schmit John H. Wallace Teacher Fellow Hamilton High School 327 Fairgrounds Road Hamilton, MT 59840 [email protected] Table Of Contents Teacher Guide Overview...................................................................................................................1 Science Background..................................................................................................1 Student Outcomes......................................................................................................4 Learning Objectives....................................................................................................4 Time Requirements.....................................................................................................4 Advance Preparation...................................................................................................4 Materials and Equipment............................................................................................4 Student Prior Knowledge............................................................................................6 What Is Expected From the Students..........................................................................7 Anticipated Results.....................................................................................................7 Classroom Discussion.................................................................................................8
    [Show full text]
  • Ecology of Pathogenic E.Coli - Stefano Morabito
    MEDICAL SCIENCES - Ecology Of Pathogenic E.Coli - Stefano Morabito ECOLOGY OF PATHOGENIC E. coli Stefano Morabito European Reference Laboratory for Escherichia coli including VTEC. Foodborne zoonoses Unit; Department of Veterinary Public Health and Food Safety Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome. Italy. Keywords: Escherichia coli, pathogenicity, genomic plasticity, survival, environment, colonization, animal reservoirs, zoonosis. Contents 1. Introduction 2. Pathogenic E. coli types 3. Ecology of Pathogenic E. coli Circulating in Humans 4. The Zoonotic Connection 5. Ecology of Zoonotic E. coli 6. Pathogenic Escherichia coli Producing Biofilm 7. Signaling In the Gastro-Intestinal Tract and Pathogenesis 8. E. coli Pathotypes with Atypical Combination of Virulence Factors 9. Acknowledgments Glossary Bibliography Biographical Sketch Summary Escherichia coli is a ubiquitous bacterial species. It is part of the intestinal microflora of humans and warm-blooded animals and, at the same time, is among the most diffuse bacterial species in the environment. The pivotal aspect of this success is represented by an exceptional genomic plasticity. As a matter of fact, E. coli is capable to exchange genetic material with other bacteria, often belonging to different species, through horizontal gene transfer, a process involving the action of mobile genetic elements, such as bacteriophages, transposons, pathogenicity islands and plasmids. The relationships between E. coli and the human host are generally based on commensalism and yet this species exerts a beneficial effect in the gut, however, some strains evolved the capability to harm and cause disease either involving the gastro- intestinal tract or in other organism‘s districts. Most of the pathogenic E.
    [Show full text]
  • Genomic Characterization of Human Adenovirus Type 4 Strains Isolated
    Virology 538 (2019) 11–23 Contents lists available at ScienceDirect Virology journal homepage: www.elsevier.com/locate/virology Genomic characterization of human adenovirus type 4 strains isolated T worldwide since 1953 identifies two separable phylogroups evolving at different rates from their most recent common ancestor ∗ Gabriel Gonzaleza, ,1, Camden R. Bairb,1, Daryl M. Lamsonc, Hidemi Watanabed, Laura Pantod, ∗∗ Michael J. Carre,f, Adriana E. Kajonb, a Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan b Infectious Disease Program, Lovelace Respiratory Research Institute, New Mexico, USA c Wadsworth Center, New York State Department of Health, New York, USA d Graduate School of Information Science and Technology, Hokkaido University, Japan e Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Japan f National Virus Reference Laboratory, School of Medicine, University College Dublin, Ireland ARTICLE INFO ABSTRACT Keywords: Species Human mastadenovirus E (HAdV-E) comprises several simian types and a single human type: HAdV-E4, a Adenovirus type 4 respiratory and ocular pathogen. RFLP analysis for the characterization of intratypic genetic variability has Human mastadenovirus E previously distinguished two HAdV-E4 clusters: prototype (p)-like and a-like. Our analysis of whole genome Genetic diversity sequences confirmed two distinct lineages, which we refer to as phylogroups (PGs). PGs I and II comprisethep- Evolution and a-like genomes, respectively, and differ significantly in their G + C content (57.7% ±0.013vs 56.3% ± 0.015). Sequence differences distinguishing the two clades map to several regions of the genome including E3 and ITR. Bayesian analyses showed that the two phylogroups diverged approximately 602 years before the present.
    [Show full text]